ABU DHABI, United Arab Emirates, Oct. 21, 2025 (GLOBE NEWSWIRE) — Appian Capital Advisory Limited (“Appian”), the investment advisor to long-term value-focused private capital funds that invest in companies in metals, mining, and adjacent industries, announces the launch of a critical minerals, metals and mining fund for emerging markets (the “Fund”) in partnership with International […]

MTC Namibia, the largest mobile operator in Namibia, has signed an exclusive interworking agreement with VOX Solutions for the direct termination of international A2P SMS and A2P Voice (OTP Voice/Flash Calls) traffic into its network. Through this agreement, VOX Solutions becomes the sole authorized channel for all international A2P traffic directed to MTC Namibia, effectively

— Highly experienced hires bring robust operational and technical expertise — Momentum builds at Astraveus following exceptional additions of Jean-Paul Mangeolle, David Newble, and Laurence Riot Lamotte earlier this year Astraveus SAS (“Astraveus” or the “Company”), the Benchtop Cell Factory company, today announces that it has further strengthened its world class leadership team with the

Appian and IFC partner to launch new US$1 billion critical minerals and metals fund for emerging markets GlobeNewswire October 21, 2025 ABU DHABI, United Arab Emirates, Oct. 21, 2025 (GLOBE NEWSWIRE) — Appian Capital Advisory Limited (“Appian”), the investment advisor to long-term value-focused private capital funds that invest in companies in metals, mining, and adjacent

(TSE:4565.T), HTL0039732 (also known as NXE0039732) is Nxera's novel oral EP4 antagonist with the potential to treat a wide range of cancers in combination with other immunotherapies HTL0039732, was found to be well-tolerated, confirmed target engagement and demonstrated encouraging early efficacy in two distinct tumor types when administered in combination use with atezolizumab Phase 1

Nxera's Partner Cancer Research UK Presents Data from Successfully Completed Phase 1 Clinical Trial of Cancer Immunotherapy Drug HTL0039732 at ESMO GlobeNewswire October 21, 2025 HTL0039732 (also known as NXE0039732) is Nxera's novel oral EP4 antagonist with the potential to treat a wide range of cancers in combination with other immunotherapies HTL0039732, was found to

(NYSE:SPNT), HAMILTON, Bermuda, Oct. 21, 2025 (GLOBE NEWSWIRE) — SiriusPoint Ltd. (“SiriusPoint”) (NYSE: SPNT), a global specialty insurer and reinsurer, has today announced the appointment of Will Nihan as Chief Executive Officer at International Medical Group (“IMG”). IMG is SiriusPoint's wholly owned subsidiary and a leader in global insurance benefits and assistance services. Mr. Nihan

SiriusPoint Announces Will Nihan as IMG CEO GlobeNewswire October 21, 2025 HAMILTON, Bermuda, Oct. 21, 2025 (GLOBE NEWSWIRE) — SiriusPoint Ltd. (“SiriusPoint”) (NYSE: SPNT), a global specialty insurer and reinsurer, has today announced the appointment of Will Nihan as Chief Executive Officer at International Medical Group (“IMG”). IMG is SiriusPoint's wholly owned subsidiary and a

Wondershare, a global leader in creative and productivity solutions, today announced the launch of the ToMoviee AI Spooktacular Video Challenge, a global user-generated content (UGC) campaign that invites creators to unleash their creativity and bring their Halloween imagination to life using ToMoviee AI, Wondershare's advanced AI video generation platform. The event runs until October 31,

ACORD Solutions Group, the leading provider of digital data exchange solutions for the global insurance industry, announced today that Echo Re has begun using the ADEPT platform to receive digital accounting and claims messages from Gallagher Re, pioneering cutting-edge methods for this type of data exchange. https://mma.prnewswire.com/media/1419070/ACORDSolutionsGroup_Logo.jpg ADEPT (ACORD Data Exchange Platform and Translator) enables